HYPR Prakiraan rega marang bathi Hyperfine Inc

The market trend for Hyperfine, Inc. (HYPR) shown on this price chart demonstrates the 0.00 indicator. Hyperfine, Inc. (HYPR) develops high-tech devices for deep health analysis. The company generates revenue through the sale of portable MRI scanners for intensive care units and mobile centers, as well as via cloud software. The business relies on an autonomous development cycle, making it resilient to global crises and a reliable defensive asset.

HYPR - Kapitalisasi marang proyeksi bathi hyperfine.io ing rentang 04.07.2022 - 11.11.2026

Rincian metrik keuangan lan pasar Hyperfine Medical (HYPR)

- nilai saham lan prakiraan konsensus rega:

Bagan rega Hyperfine|HYPR - Target median analis

- data kapitalisasi pasar:

Biji pasar Hyperfine Inc|HYPR - Total Nilai Bisnis

- statistik nilai buku emiten:

Nilai Buku saben Saham Hyperfine|HYPR - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku hyperfine.io|HYPR - Gunggung Aset Perusahaan

- informasi babagan utang lan solvabilitas:

- statistik bathi lan rasio pasar:

HYPR - Asil keuangan resik|Proyeksi bathi mangsa ngarep Hyperfine, Inc.|HYPR - Koefisien rega marang bathi|Pangali Forward P/E Hyperfine Corp|HYPR - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Hyperfine Inc|HYPR - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Hyperfine|HYPR - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan hyperfine.io|HYPR - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Hyperfine, Inc.

Analisis fundamental perusahaan:Hyperfine

Evaluating future earnings is critical for identifying the fundamental drivers of stability for Hyperfine, Inc. (HYPR). This indicator compares the current market price with projected net income, accounting for solvency risks and debt load. The trend of the company's expected P/E ratio allows for the rapid identification of whether the asset is undervalued or overpriced. A declining ratio may signal liquidity issues, which is particularly significant for scaling sales of Swoop portable MRI scanners featuring AI reconstruction.

Pesaing Hyperfine, Inc. (HYPR)

Rega marang bathi mangsa ngarep Abbott (ABT)|Kapitalisasi marang proyeksi bathi Thermo Fisher Scientific Inc.|GE Healthcare Corp - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep MTD (Mettler Toledo Inc)|Waters Corporation - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi bio-techne.com TECH|BRKR: Pangali Forward P/E|Prakiraan rega marang bathi Azenta Inc|Prakiraan rega marang bathi VREX|SMLR: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Butterfly Network, Inc. (BFLY)|Prakiraan rega marang bathi mesalabs.com MLAB|Pangali Forward P/E QSI (Quantum-Si Incorporated)|Nano-X Imaging (NNOX) - Rasio prakiraan rega marang bathi|Quanterix Corp - Pangali Forward P/E|MASS (908 Devices Corporation) - Rasio rega marang bathi mangsa ngarep|CV: Pangali Forward P/E|MXCT - Kapitalisasi marang proyeksi bathi|RPID (Rapid Micro Biosystems Inc.) - Pangali Forward P/E|Prakiraan rega marang bathi Seer Inc (SEER)|Pangali Forward P/E FONR|Pangali Forward P/E daxor.com (DXR)|Rega marang bathi mangsa ngarep Spectral AI MDAI|organovo.com - Rega marang bathi mangsa ngarep|ACON: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi AKYA (Akoya Biosciences)|THMO: Pangali Forward P/E|Rasio prakiraan rega marang bathi Talis Biomedical Corporation (TLIS)|Rega marang bathi mangsa ngarep T2 Biosystems, Inc.